Recruiting
Phase 2

Epoprostenol & Milrinone

Sponsor:

Montreal Heart Institute

Code:

NCT05450328

Conditions

Right Heart Failure

Right Ventricular Dysfunction

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Combined Epoprostenol Sodium & Milrinone

Normal saline

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-10. This information was provided to ClinicalTrials.gov by Montreal Heart Institute on 2026-06-25.